In a groundbreaking medical advancement, researchers have genetically engineered the hookworm Ancylostoma ceylanicum to function as an internal drug delivery system. This first-of-its-kind study demonstrates the parasite's ability to produce specific antibodies within a living host.
The modified worms successfully generated antitoxins capable of partially neutralizing tetrodotoxin, a potent neurotoxin found in pufferfish. This innovation suggests a future where biological vectors can administer targeted therapies directly inside the human body, bypassing traditional delivery methods.